DK0658168T3 - Antistoffer, som er specifikke for et hæmostatisk protein, anvendelse heraf til isolering af intakt protein, hæmostatiske p - Google Patents

Antistoffer, som er specifikke for et hæmostatisk protein, anvendelse heraf til isolering af intakt protein, hæmostatiske p

Info

Publication number
DK0658168T3
DK0658168T3 DK93921129T DK93921129T DK0658168T3 DK 0658168 T3 DK0658168 T3 DK 0658168T3 DK 93921129 T DK93921129 T DK 93921129T DK 93921129 T DK93921129 T DK 93921129T DK 0658168 T3 DK0658168 T3 DK 0658168T3
Authority
DK
Denmark
Prior art keywords
hemostatic
protein
isolation
intact
proteins
Prior art date
Application number
DK93921129T
Other languages
English (en)
Inventor
Koenraad Mertens
Mourik Jan Aart Van
Original Assignee
Sanquin Bloedvoorziening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanquin Bloedvoorziening filed Critical Sanquin Bloedvoorziening
Application granted granted Critical
Publication of DK0658168T3 publication Critical patent/DK0658168T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK93921129T 1992-08-27 1993-08-26 Antistoffer, som er specifikke for et hæmostatisk protein, anvendelse heraf til isolering af intakt protein, hæmostatiske p DK0658168T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92202615 1992-08-27
PCT/NL1993/000174 WO1994005692A1 (en) 1992-08-27 1993-08-26 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein

Publications (1)

Publication Number Publication Date
DK0658168T3 true DK0658168T3 (da) 2001-01-22

Family

ID=8210886

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93921129T DK0658168T3 (da) 1992-08-27 1993-08-26 Antistoffer, som er specifikke for et hæmostatisk protein, anvendelse heraf til isolering af intakt protein, hæmostatiske p

Country Status (12)

Country Link
US (2) US5932706A (da)
EP (1) EP0658168B1 (da)
JP (1) JP3735112B2 (da)
AT (1) ATE197590T1 (da)
AU (1) AU678987B2 (da)
CA (1) CA2143125C (da)
DE (1) DE69329682T2 (da)
DK (1) DK0658168T3 (da)
ES (1) ES2152953T3 (da)
GR (1) GR3035391T3 (da)
PT (1) PT658168E (da)
WO (1) WO1994005692A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA24512A1 (fr) * 1996-01-17 1998-12-31 Univ Vermont And State Agrienl Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose
US6624289B1 (en) * 1999-06-16 2003-09-23 Saint Louis University Region of factor IXa protease domain that interacts with factor VIIIa and methods therefor
US7109170B2 (en) * 1999-06-16 2006-09-19 Saint Louis University Region of factor IXa protease domain that interacts with factor VIIIa and methods therefor
AT411997B (de) 1999-09-14 2004-08-26 Baxter Ag Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate
US20040102388A1 (en) * 2000-03-22 2004-05-27 High Katherine A. Modified blood clotting factors and methods of use
IL162239A0 (en) 2001-12-21 2005-11-20 Novo Nordisk Healthcare Ag Liquid composition of factor vii polypeptides
DK2283856T3 (da) 2002-06-21 2017-11-20 Novo Nordisk Healthcare Ag Stabiliserede, faste sammensætninger af Faktor VIIa-polypeptider
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
KR20060015574A (ko) 2003-05-23 2006-02-17 노보 노르디스크 헬스 케어 악티엔게젤샤프트 용액 중 단백질 안정화
EP1641487B1 (en) 2003-06-25 2012-02-29 Novo Nordisk Health Care AG Liquid composition of factor vii polypeptides
KR101293503B1 (ko) 2003-08-14 2013-08-07 노보 노르디스크 헬스 케어 악티엔게젤샤프트 인자 ｖｉｉ 폴리펩티드의 액상 수성 약학적 조성물
US7297336B2 (en) 2003-09-12 2007-11-20 Baxter International Inc. Factor IXa specific antibodies displaying factor VIIIa like activity
FR2863616A1 (fr) * 2003-12-12 2005-06-17 Stago Diagnostica Dosage de la proteine s libre non clivee par le facteur xa et utilisation de ce dosage pour l'evaluation du potentiel de coagulation
EP1831242B1 (en) * 2004-12-23 2012-09-26 Novo Nordisk Health Care AG Reduction of the content of protein contaminants in compositions comprising a vitamin k-dependent protein of interest
EP1904528B1 (en) * 2005-07-13 2012-10-31 Novo Nordisk Health Care AG Host cell protein knock-out cells for production of therapeutic proteins
CN103025757A (zh) 2010-04-29 2013-04-03 巴克斯特国际有限公司 二价阳离子结合蛋白在阴离子交换树脂上的纯化方法
AU2012322948B2 (en) * 2011-10-14 2014-11-06 Takeda Pharmaceutical Company Limited Protein purification by anion exchange chromatography
ES2700933T3 (es) 2011-10-14 2019-02-20 Baxalta GmbH Purificación de proteínas mediante cromatografía de intercambio aniónico
SI2970376T1 (sl) 2013-03-15 2018-09-28 Baxalta Incorporated Metoda čiščenja za vitamin k odvisne proteine z anionsko izmenjevalno kromatografijo
CA3051639A1 (en) 2017-02-01 2018-08-09 Novo Nordisk A/S Procoagulant antibodies
US11220554B2 (en) 2018-09-07 2022-01-11 Novo Nordisk A/S Procoagulant antibodies
JP2023524807A (ja) 2020-05-05 2023-06-13 ベガ・セラピューティクス・インコーポレイテッド プロテインｓ抗体、その作製方法および使用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252712A (en) * 1980-10-20 1993-10-12 New England Medical Center Hospitals, Inc. Purified antibodies which specifically bind human abnormal prothrombin
US5055557A (en) * 1983-03-04 1991-10-08 Scripps Clinic & Research Foundation Ultrapurification of factor IX and other vitamin K-dependent proteins
US4637932A (en) * 1984-10-15 1987-01-20 Miles Laboratories, Inc. Process for producing a concentrate enriched in coagulation factors VII and VIIa
ATE130620T1 (de) * 1986-01-06 1995-12-15 Blood Systems Inc Therapeutisches blutprodukt, mittel und verfahren zu dessen erzeugung.
DE3740520A1 (de) * 1987-11-30 1989-06-08 Hans Dr Rer Nat Scheefers Schnelles verfahren zur gewinnung einer faktor vii - praeparation sowie ihre verwendung
FI86339C (fi) * 1988-12-09 1992-08-10 Ari Tuomi Diffusionscell foer undersoekning av salvor och liknande.
CA2006684C (en) * 1988-12-30 1996-12-17 Charles T. Esmon Monoclonal antibody against protein c
US5202253A (en) * 1988-12-30 1993-04-13 Oklahoma Medical Research Foundation Monoclonal antibody specific for protein C and antibody purification method
AT402153B (de) * 1989-06-26 1997-02-25 Immuno Ag Protein-s-hältige pharmazeutische präparation
RU2142806C1 (ru) * 1991-03-01 1999-12-20 Сентеон Л.Л.С. Способ очистки и хранения фактора ix, водный раствор очищенного фактора ix, композиция, содержащая фактор ix, способ лечения
DE4329517C2 (de) * 1993-08-30 1996-04-04 Schuelke & Mayr Gmbh Waschende Händedesinfektions- und Händedekontaminationsmittel auf Basis naturidentischer, aromatischer Alkohole
AU674586B2 (en) * 1994-07-27 1997-01-02 Rain Bird Sprinkler Manufacturing Corporation Speed controlled rotating sprinkler

Also Published As

Publication number Publication date
JPH08500833A (ja) 1996-01-30
PT658168E (pt) 2001-04-30
CA2143125A1 (en) 1994-03-17
AU4835993A (en) 1994-03-29
ES2152953T3 (es) 2001-02-16
US5932706A (en) 1999-08-03
USRE38202E1 (en) 2003-07-22
ATE197590T1 (de) 2000-12-15
EP0658168B1 (en) 2000-11-15
JP3735112B2 (ja) 2006-01-18
AU678987B2 (en) 1997-06-19
GR3035391T3 (en) 2001-05-31
CA2143125C (en) 2008-09-23
DE69329682D1 (de) 2000-12-21
WO1994005692A1 (en) 1994-03-17
DE69329682T2 (de) 2001-05-17
EP0658168A1 (en) 1995-06-21

Similar Documents

Publication Publication Date Title
DK0658168T3 (da) Antistoffer, som er specifikke for et hæmostatisk protein, anvendelse heraf til isolering af intakt protein, hæmostatiske p
DK532284D0 (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
DE69228701D1 (de) Fragmente von Prion Proteinen.
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
DE69331011D1 (de) Durch aldehyd geharteterklebstoff auf basis von protein
DE69703449D1 (de) Neuroaktive peptide
DK0933082T3 (da) Fremgangsmåde til manipulation af celledifferentiering
WO1996040885A3 (en) β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION
EP1264890A3 (en) Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
AU640699B2 (en) Carrier for binding antiphospholipid antibody, immunoassay using the same, and kit therefor
WO2002086081A3 (en) Methods and systems for identifying proteins
ES2079621T3 (es) Procedimiento de identificacion o de titulacion de proteinas y aplicaciones.
DK0960336T3 (da) Peptidreagens til påvisning af humant cytomelagovirus (CMV)
ES539382A0 (es) Procedimiento para la determinacion de fibrina
AU5479396A (en) Epstein-Barr virus peptides and antibodies against these peptides
PT816377E (pt) Peptideos que se ligam a protrombina e a trombina
DK0607425T3 (da) Epstein-Barr-viruspeptider og antistoffer mod disse peptider
NO891713D0 (no) Monoklonale antistoffer til vevplasminogenaktivator (t-pa)
DE3855007D1 (de) METHODE ZUR REINIGUNG REKOMBINANTER t-PA VON DEN IHREN ENTSPRECHENDEN WIRTSZELLPROTEINEN
DK0396188T3 (da) Antistoffer mod fibrin, immunogene peptider til fremstilling af disse antistoffer, fremgangsmåde til bestemmelse af fibrin og farmaceutiske præparater baseret på disse antistoffer
Srinivas et al. Translocation of plasminogen activator inhibitor-1 during serum stimulated growth of mouse embryo fibroblasts